Your web browser is out of date. Update your browser for more security, speed and the best experience on this site.

Update your browser
CapTech Home Page

Client

Amy’s Army

Industry

Non-Profit

Challenge

In September of 2017, Amy’s Army of Cancer Warriors hosted their inaugural Climb to Conquer Cancer Cycling Event (C3) to help raise money to fight cancer. As a part of the event, the Amy’s Army team wanted something to set their charity ride apart from similar events, so they created two awards categories for those racers who could complete the Libby Hill portion of the race the fastest, but they needed an affordable, efficient way to track racers times.

Results
  • A custom tracking application that leveraged Strava to help track users’ times.
  • Free access to the cyclists’ data to help Amy’s Army track riders, hand out jerseys, and determine award categories, without having to dive into the funds that they raised to give to the cancer research.
  • A pop-up network infrastructure that provided the event with a Wi-Fi network used by the event team for live video streaming, registration processing, and more.

$8,500

Raised for Cancer Research

Climbing Hills For a Cause

The race offered cyclists of all abilities the opportunity to ride the infamous cobbled climb of Libby Hill, which was the major feature of the Richmond UCI 2015 World Championship course. There were 143 different cyclists who rode over 6000 combined miles during the race.

On race day, the custom solution calculated the average of a rider’s 2 passes over the Libby Hill segment and displayed their results on one of three different content displays.

CapTech has a strong cycling group, and nearly every one of the twenty CapTechers who participated in the project was a cyclist themselves. CapTech Manager, Kent Pruett said, “It was fantastic to merge our personal cycling passion along with our professional skills to deliver this solution. Not only that, but it’s exciting to play a part in something that created value for a non-profit who is doing good things for cancer research.”